Haleon (LON:HLN) Trading Up 0.1% - Time to Buy?

Key Points

• Haleon shares were essentially flat, trading at GBX 350.80 (up 0.1%) on Tuesday with volume down ~28% versus the daily average, and the stock is trading below both its 50‑day (GBX 374.24) and 200‑day (GBX 371.05) moving averages.
• Analyst sentiment is a “Moderate Buy” with an average price target of GBX 407 (four Buys, one Hold, one Sell), though recent targets vary widely from GBX 335 to GBX 512.
• An insider, Brian McNamara, sold 704,974 shares at GBX 368 (~£2.59m); Haleon has a market cap of £31.28bn, a PE of 18.96, net margin of 12.59% and a debt‑to‑equity ratio of 52.26.

Haleon plc (LON:HLN - Get Free Report) shares were up 0.1% during trading on Tuesday . The stock traded as high as GBX 352 and last traded at GBX 350.80. Approximately 22,941,566 shares traded hands during trading, a decline of 28% from the average daily volume of 31,698,201 shares. The stock had previously closed at GBX 350.30.

Analysts Set New Price Targets

Several analysts have commented on HLN shares. Deutsche Bank Aktiengesellschaft cut their target price on Haleon from GBX 340 to GBX 335 and set a "buy" rating on the stock in a research note on Thursday, January 22nd. Berenberg Bank raised their price target on Haleon from GBX 510 to GBX 512 and gave the stock a "buy" rating in a research note on Thursday, March 19th. Finally, Jefferies Financial Group restated a "buy" rating and issued a GBX 450 price target on shares of Haleon in a research note on Monday, March 30th. Four equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of GBX 407.

Haleon Trading Up 0.1%

The stock has a market capitalization of £31.28 billion, a PE ratio of 18.96, a P/E/G ratio of 1.49 and a beta of 0.33. The company has a current ratio of 0.92, a quick ratio of 0.93 and a debt-to-equity ratio of 52.26. The stock has a 50 day moving average price of GBX 374.24 and a 200-day moving average price of GBX 371.05.

Haleon (LON:HLN - Get Free Report) last released its quarterly earnings results on Thursday, February 26th. The company reported GBX 18.60 earnings per share (EPS) for the quarter. Haleon had a return on equity of 6.43% and a net margin of 12.59%. Sell-side analysts expect that Haleon plc will post 19.5033282 earnings per share for the current year.

Insiders Place Their Bets

In related news, insider Brian McNamara sold 704,974 shares of Haleon stock in a transaction on Monday, March 23rd. The stock was sold at an average price of GBX 368, for a total transaction of £2,594,304.32. Company insiders own 0.01% of the company's stock.

Haleon Company Profile

Haleon LSE / NYSE: HLN is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.